{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:01:42Z","timestamp":1790938902160,"version":"4.1.0"},"reference-count":17,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Allergy Immunology"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Walnut OIT has been observed to induce cross\u2010desensitization to hazelnut, but predictors of this response remain unclear. We sought to identify molecular predictors of hazelnut cross\u2010desensitization following walnut OIT, to help guide treatment decisions in these co\u2010allergic patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with confirmed IgE\u2010mediated walnut and hazelnut allergy underwent walnut OIT. Patients achieving full walnut desensitization to 4\u2009g of walnut protein were re\u2010challenged to 4\u2010grams hazelnut protein after 6\u2009months. Baseline sera were obtained and competitive ELISA inhibition assays performed to evaluate serum IgE cross\u2010recognition of total walnut, total hazelnut and hazelnut component\u2010specific IgE. Results were compared between patients fully (4\u2010grams protein) or clinically (\u226530\u2010fold ED increase or mild reaction at full dose) cross\u2010desensitized to hazelnut and those who remained hazelnut allergic following walnut OIT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, 12\/22 (54.5%) patients were fully cross\u2010desensitized and 14\/22 (63.6%) patients were clinically cross\u2010desensitized to hazelnut following walnut OIT. Among the latter, walnut inhibited total hazelnut\u2010specific IgE binding by a median of 95%, compared to 55% in those who remained hazelnut allergic (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.01). Similarly, walnut extract competed for IgE binding to hazelnut components Cor a 9 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.003) and Cor a 16 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.023) in the cross\u2010desensitized group following walnut OIT, but not in the persistent hazelnut allergic group. A \u226570% inhibition threshold accurately predicted cross\u2010desensitization in 93% of cases (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Walnut OIT can induce clinical cross\u2010desensitization to hazelnut in &gt;60% of co\u2010allergic individuals. Competitive ELISA inhibition is a promising predictive tool, with potential to guide targeted and efficient OIT strategies in walnut\u2010hazelnut co\u2010allergic patients.<\/jats:p>\n                    <jats:p>\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/pai70500-gra-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/pai.70500","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:50:14Z","timestamp":1790938214000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inhibition studies to direct oral immunotherapy in walnut\u2010hazelnut co\u2010allergic patients (nut CRACKER study)"],"prefix":"10.1111","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5232-6342","authenticated-orcid":false,"given":"Yael","family":"Koren","sequence":"first","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"},{"name":"Department of Pediatrics Shamir Medical Center, Zerifin, Israel, Affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9089-9472","authenticated-orcid":false,"given":"Michael Y.","family":"Appel","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9523-5616","authenticated-orcid":false,"given":"Matan","family":"Elkan","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"},{"name":"Department of Medicine Shamir Medical Center, Zerifin, Israel, Affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-472X","authenticated-orcid":false,"given":"Liat","family":"Nachshon","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"},{"name":"Department of Medicine Shamir Medical Center, Zerifin, Israel, Affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0962-7814","authenticated-orcid":false,"given":"Lars","family":"Mattsson","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-3411","authenticated-orcid":false,"given":"Jonas","family":"Lidholm","sequence":"additional","affiliation":[{"name":"Thermo Fisher Scientific  Uppsala Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Levy","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-8143","authenticated-orcid":false,"given":"Arnon","family":"Elizur","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"},{"name":"Department of Pediatrics Shamir Medical Center, Zerifin, Israel, Affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-1533","authenticated-orcid":false,"given":"Michael R.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Institute of Allergy, Immunology and Pediatric Pulmonology Shamir (Assaf Harofeh) Medical Center  Be'er Ya'akov Israel"},{"name":"Department of Pediatrics Shamir Medical Center, Zerifin, Israel, Affiliated to the Gray Faculty of Medical and Health Sciences, Tel Aviv University  Tel Aviv Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"9","key":"e_1_2_11_2_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11882-015-0555-8","article-title":"The prevalence of tree nut allergy: a systematic review","volume":"15","author":"McWilliam V","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"e_1_2_11_3_1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/all.13353","article-title":"NUT Co reactivity \u2010 ACquiring knowledge for elimination recommendations (NUT CRACKER) study","volume":"73","author":"Elizur A","year":"2018","journal-title":"Allergy"},{"issue":"5","key":"e_1_2_11_4_1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2017.06.031","article-title":"Fatal anaphylaxis: mortality rate and risk factors","volume":"5","author":"Turner PJ","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"e_1_2_11_5_1","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14132","article-title":"Current options in the management of tree nut allergy: a systematic review and narrative synthesis","volume":"35","author":"Pasioti M","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"issue":"5","key":"e_1_2_11_6_1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/pai.12914","article-title":"Long\u2010term outcome of peanut oral immunotherapy\u2010real\u2010life experience","volume":"29","author":"Nachshon L","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(19)30029-X"},{"issue":"6","key":"e_1_2_11_8_1","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/all.15212","article-title":"Cashew oral immunotherapy for desensitizing cashew\u2010pistachio allergy (NUT CRACKER study)","volume":"77","author":"Elizur A","year":"2022","journal-title":"Allergy"},{"issue":"7","key":"e_1_2_11_9_1","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/cea.13163","article-title":"Tree nut allergies: allergen homology, cross\u2010reactivity, and implications for therapy","volume":"48","author":"Smeekens JM","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"e_1_2_11_10_1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.23822\/EurAnnACI.1764-1489.54","article-title":"Storage molecules from tree nuts, seeds and legumes: relationships and amino acid identity among homologue molecules","volume":"50","author":"Scala E","year":"2018","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"1","key":"e_1_2_11_11_1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000492399","article-title":"Evidence of cross\u2010reactivity between different seed storage proteins from hazelnut (Corylus avellana) and walnut (Juglans regia) using recombinant allergen proteins","volume":"178","author":"Villalta D","year":"2019","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"e_1_2_11_12_1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaip.2024.12.041","article-title":"Hazelnut oral immunotherapy desensitizes hazelnut but not other tree nut allergies (nut CRACKER study)","volume":"13","author":"Elizur A","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"e_1_2_11_13_1","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.jaci.2012.10.017","article-title":"Standardizing double\u2010blind, placebo\u2010controlled oral food challenge: American Academy of Allergy, Asthma & Immunology\u2010 European academy of allergy and clinical immunology PRACTALL consensus report","volume":"130","author":"Sampson HA","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_11_14_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1398-9995.2004.00466.x","article-title":"European academy of allergology and clinical immunology. Standardization of food challenges in patients with immediate reactions to foods\u2010\u2010position paper from the European academy of allergology and clinical immunology","volume":"59","author":"Bindslev\u2010Jensen C","year":"2004","journal-title":"Allergy"},{"key":"e_1_2_11_15_1","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jaci.2021.12.789","article-title":"Updating the CoFAR grading scale for systemic allergic reactions in food allergy","volume":"149","author":"Chinthrajah RS","year":"2022","journal-title":"J Allergy Clin Immunol"},{"issue":"32","key":"e_1_2_11_16_1","doi-asserted-by":"crossref","first-page":"18162","DOI":"10.1021\/acs.jafc.4c03603","article-title":"Walnut jug r 1 is responsible for primary sensitization among patients suffering walnut\u2010hazelnut 2S albumin cross\u2010reactivity","volume":"72","author":"Castromil\u2010Benito ES","year":"2024","journal-title":"J Agric Food Chem"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/foods10061235"},{"issue":"1","key":"e_1_2_11_18_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.18176\/jiaci.0867","article-title":"Cosensitization to the 3 nonhomologous major cashew allergens ana o 1, ana o 2, and ana o 3 is caused by IgE cross\u2010reactivity","volume":"34","author":"Kabasser S","year":"2024","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Pediatric Allergy and Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.70500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pai.70500","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pai.70500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:50:17Z","timestamp":1790938217000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pai.70500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1111\/pai.70500"],"URL":"https:\/\/doi.org\/10.1111\/pai.70500","archive":["Portico"],"relation":{},"ISSN":["0905-6157","1399-3038"],"issn-type":[{"value":"0905-6157","type":"print"},{"value":"1399-3038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"2026-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70500"}}